Lataa...
Reflections on the Importance of Cost of Illness Analysis in Rare Diseases: A Proposal
In the field of rare diseases (RDs), the evidence standard is often lower than that required by health technology assessment (HTA) and payer authorities. In this commentary, we propose that appropriate economic evaluation for rare disease treatments should be initially informed by cost-of-illness (C...
Tallennettuna:
| Julkaisussa: | Int J Environ Res Public Health |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
MDPI
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7908548/ https://ncbi.nlm.nih.gov/pubmed/33530652 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijerph18031101 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|